IOL Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹795 crore and net profit of ₹65 crore for the September 2026 quarter.
IOL Chemicals (NSE: IOLCP) closed at ₹184.12 on 20 Nov 2026, up 101.0% over the past year. Its market capitalisation is ₹5,404 crore and it trades at 25.5 times earnings.
IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market. It is the largest player of Ibuprofen (pain killer) globally with a world market share of 35%.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.